期刊文献+

布洛芬包合物温敏凝胶药动学及其对注射部位的刺激性 被引量:3

Pharmacokinetics and injection site irritation of ibuprofen inclusion complex thermosensitive in situ gel
原文传递
导出
摘要 目的:考察布洛芬包合物温敏凝胶在兔体内的药动学行为及其对注射部位的刺激性。方法:采用HPLC内标法测定了不同时间点的血药浓度,3P97软件进行房室模型的拟合和药动学参数的计算,光镜下观察对照组、空白凝胶组、凝胶低剂量组和高剂量组、水溶液组注射部位的病理切片。结果:布洛芬包合物温敏凝胶体内释放规律符合Weight为1/C2的二室模型,Cmax(5.81±0.65)μg·ml-1,Tpeak(101.77±2.59)h,AUC(0-t)(1 619.13±36.51)μg·min·ml-1。兔注射部位肌肉组织结构正常,横纹清晰,未见坏死肌细胞。结论:布洛芬包合物温敏凝胶能够延长达峰时间,显著提高生物利用度,且对注射部位无明显刺激性,生物相容性好。 OBJECTIVE To evaluate the pharmacokinetics and injection site irritation of ibuprofen inclusion complex thermo- sensitive in situ gel in New Zealand white rabbits. METHODS The ibuprofen concentrations in serum were determined by HPLC. The pharmacokinetic parameters of ibuprofen and the fitting of compartment model were analyzed using 3P97 program. The pathological sections in injection site of control group, blank gel group, low dose group, high dose group and ibuprofen a queous solution group were observed under the light microscope. RESULTS The drug release from ibuprofen inclusion complex thermosensitive in situ gel followed two-compartment model with 1/C2 as weight. The pharmacokinetic parameters were as fol lows: Cmax(5.81 ± 0. 65)/lg.mL 1;Tpeak(101.77±2.59)h;AUC(0-t)(1619. 13±36.51)μg.min.ml-1. CONCLUSION The ibu profen inclusion complex thermosensitive in situ gels significantly extended Tpeak and increased the bioavailability without notice able irritation to the injection site.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2014年第4期296-299,共4页 Chinese Journal of Hospital Pharmacy
关键词 包合物 温敏凝胶 药动学 刺激性 布洛芬 inclusion complex thermosensitive in situ gel pharmacokinetics irritation ibuprofen
  • 相关文献

参考文献8

二级参考文献36

共引文献25

同被引文献40

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部